Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 07/02/24 07:01:00 on US and Canada Markets.
Garmin selected as exclusive marine electronics and audio supplier to IBBI through 2029 PR Newswire Long-term agreement includes Garmin, JL Audio, Fusion and Clarion Marine products OLATHE, Kan. , July 2, 2024 /PRNewswire/ -- Garmin (NYSE: GRMN), the...
WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has completed the resubmission of its Biologics License Application (“BLA”) t...
WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has completed the resubmission of its Biologics License Application (“BLA”) t...
China Yuchai International Limited (CYD) is expected to report for Q1 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Derwent London Plc (DWVYF) is expected to report for Q1 2024 Fresnillo Plc (FNLPF) is expected to report for Q1 2024 Basilea Pharmaceutic...
China Yuchai International Limited (CYD) is expected to report for Q1 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Derwent London Plc (DWVYF) is expected to report for Q1 2024 Fresnillo Plc (FNLPF) is expected to report for Q1 2024 Basilea Pharmaceutic...
China Yuchai International Limited (CYD) is expected to report for Q1 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Derwent London Plc (DWVYF) is expected to report for Q1 2024 Fresnillo Plc (FNLPF) is expected to report for Q1 2024 Basilea Pharmaceutic...
2024-07-02 07:00:04 ET Bose George from National Bank issued a price target of $53.00 for FNF on 2024-07-02 05:31:00. The adjusted price target was set to $53.00. At the time of the announcement, FNF was trading at $48.58. The overall price target consensus is at $60.50 ...
2024-07-02 07:00:04 ET Michael Rose from Raymond James issued a price target of $60.00 for CMA on 2024-07-02 05:26:00. The adjusted price target was set to $60.00. At the time of the announcement, CMA was trading at $50.8. The overall price target consensus is at $76.87 ...
Blue Owl Capital Completes Acquisition of Kuvare Asset Management PR Newswire NEW YORK , July 2, 2024 /PRNewswire/ -- Blue Owl Capital Inc. ("Blue Owl") (NYSE: OWL), a leading alternative asset manager, announced today the completion of its acquisition of Ku...
KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
10.2%Change Percent:
PolyPid Ltd. Company Name:
PYPD Stock Symbol:
NASDAQ Market:
polypid.com Website: